TWST Twist Bioscience Corporation

NASDAQ
$116.35

Twist Bioscience Corporation (TWST) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is a loss of $0.35 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +16.7% since its last earnings release on November 12, 2026.

Twist Bioscience Beat Expectations, Sees First Quarter Above Estimates, but Guides In-line for the Year
Thursday, November 12, 2026 · 7:15 AM ET
Earnings Date
1st Quarter, Dec 2026
Feb 11
Thursday · 7:15 AM ET
Earnings Whisper
-
vs ($0.35)
Rev est $130.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $112.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.